Skip to main content
Premium Trial:

Request an Annual Quote

CMI Establishes Initiative to Advance Next-Generation Drug Discovery

NEW YORK, March 29 (GenomeWeb News) - The Cambridge-MIT Institute said last week that it is launching a new initiative to bring researchers from different disciplines together to help accelerate advances in drug discovery.


CMI said it is funding the Next-Generation Drug Discovery Community, which will unite CambridgeUniversityand MIT researchers from fields such as computer science and physics with partners from the information technology and biopharmaceutical industries.


According to CMI, the alliance will work on new methods of overcoming bottlenecks in the drug discovery and development process. The effort is designed to advance the development of techniques for the rapid and quantitative experimental measurement of the gene- and protein-level properties of cells and tissues simultaneously, as well as to offer computer-aided analysis of the meaning of these data.


The community's first projects will involve studying adult blood stem cells as experimental systems for testing the efficacy and toxicity of drugs, and establishing new computational methods to identify drug targets, said CMI.


The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.